Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Ferreira Cristina S, Polo B, Lacerda JF.

Semin Hematol. 2018 Oct;55(4):215-222. doi: 10.1053/j.seminhematol.2018.04.005. Epub 2018 Apr 17. Review.

PMID:
30502850
2.

Molecular Markers Distinguishing T Cell Subtypes With TSDR Strand-Bias Methylation.

Minskaia E, Saraiva BC, Soares MMV, Azevedo RI, Ribeiro RM, Kumar SD, Vieira AIS, Lacerda JF.

Front Immunol. 2018 Nov 5;9:2540. doi: 10.3389/fimmu.2018.02540. eCollection 2018.

3.

Genetic deficiency of NOD2 confers resistance to invasive aspergillosis.

Gresnigt MS, Cunha C, Jaeger M, Gonçalves SM, Malireddi RKS, Ammerdorffer A, Lubbers R, Oosting M, Rasid O, Jouvion G, Fitting C, Jong DJ, Lacerda JF, Campos A Jr, Melchers WJG, Lagrou K, Maertens J, Kanneganti TD, Carvalho A, Ibrahim-Granet O, van de Veerdonk FL.

Nat Commun. 2018 Jul 6;9(1):2636. doi: 10.1038/s41467-018-04912-3.

4.

Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis.

Kyrmizi I, Ferreira H, Carvalho A, Figueroa JAL, Zarmpas P, Cunha C, Akoumianaki T, Stylianou K, Deepe GS Jr, Samonis G, Lacerda JF, Campos A Jr, Kontoyiannis DP, Mihalopoulos N, Kwon-Chung KJ, El-Benna J, Valsecchi I, Beauvais A, Brakhage AA, Neves NM, Latge JP, Chamilos G.

Nat Microbiol. 2018 Jul;3(7):791-803. doi: 10.1038/s41564-018-0167-x. Epub 2018 May 30.

PMID:
29849062
5.

Recognition of DHN-melanin by a C-type lectin receptor is required for immunity to Aspergillus.

Stappers MHT, Clark AE, Aimanianda V, Bidula S, Reid DM, Asamaphan P, Hardison SE, Dambuza IM, Valsecchi I, Kerscher B, Plato A, Wallace CA, Yuecel R, Hebecker B, da Glória Teixeira Sousa M, Cunha C, Liu Y, Feizi T, Brakhage AA, Kwon-Chung KJ, Gow NAR, Zanda M, Piras M, Zanato C, Jaeger M, Netea MG, van de Veerdonk FL, Lacerda JF, Campos A, Carvalho A, Willment JA, Latgé JP, Brown GD.

Nature. 2018 Mar 15;555(7696):382-386. doi: 10.1038/nature25974. Epub 2018 Feb 28.

6.

Widening the spectrum of deletions and molecular mechanisms underlying alpha-thalassemia.

Ferrão J, Silva M, Gonçalves L, Gomes S, Loureiro P, Coelho A, Miranda A, Seuanes F, Reis AB, Pina F, Maia R, Kjöllerström P, Monteiro E, Lacerda JF, Lavinha J, Gonçalves J, Faustino P.

Ann Hematol. 2017 Nov;96(11):1921-1929. doi: 10.1007/s00277-017-3090-y. Epub 2017 Sep 8.

PMID:
28887661
7.

Correction: The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.

Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A.

J Exp Med. 2017 May 1;214(5):1559. doi: 10.1084/jem.2015028204172017c. Epub 2017 Apr 18. No abstract available.

8.

IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity.

Cunha C, Gonçalves SM, Duarte-Oliveira C, Leite L, Lagrou K, Marques A, Lupiañez CB, Mesquita I, Gaifem J, Barbosa AM, Pinho Vaz C, Branca R, Campilho F, Freitas F, Ligeiro D, Lass-Flörl C, Löffler J, Jurado M, Saraiva M, Kurzai O, Rodrigues F, Castro AG, Silvestre R, Sainz J, Maertens JA, Torrado E, Jacobsen ID, Lacerda JF, Campos A Jr, Carvalho A.

J Allergy Clin Immunol. 2017 Sep;140(3):867-870.e9. doi: 10.1016/j.jaci.2017.02.034. Epub 2017 Apr 4. No abstract available.

PMID:
28389392
9.

Low-dose IL-2 selectively activates subsets of CD4+ Tregs and NK cells.

Hirakawa M, Matos TR, Liu H, Koreth J, Kim HT, Paul NE, Murase K, Whangbo J, Alho AC, Nikiforow S, Cutler C, Ho VT, Armand P, Alyea EP, Antin JH, Blazar BR, Lacerda JF, Soiffer RJ, Ritz J.

JCI Insight. 2016 Nov 3;1(18):e89278.

10.

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells.

Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A.

J Exp Med. 2016 Sep 19;213(10):2167-85. doi: 10.1084/jem.20150282. Epub 2016 Sep 12. Erratum in: J Exp Med. 2017 May 1;214(5):1559.

11.

Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD.

Alho AC, Kim HT, Chammas MJ, Reynolds CG, Matos TR, Forcade E, Whangbo J, Nikiforow S, Cutler CS, Koreth J, Ho VT, Armand P, Antin JH, Alyea EP, Lacerda JF, Soiffer RJ, Ritz J.

Blood. 2016 Feb 4;127(5):646-57. doi: 10.1182/blood-2015-10-672345. Epub 2015 Dec 15.

12.

Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis.

Oliveira-Coelho A, Rodrigues F, Campos A Jr, Lacerda JF, Carvalho A, Cunha C.

Front Microbiol. 2015 May 5;6:411. doi: 10.3389/fmicb.2015.00411. eCollection 2015. Review.

13.

Adult B-cell acute lymphoblastic leukemia cells display decreased PTEN activity and constitutive hyperactivation of PI3K/Akt pathway despite high PTEN protein levels.

Gomes AM, Soares MV, Ribeiro P, Caldas J, Póvoa V, Martins LR, Melão A, Serra-Caetano A, de Sousa AB, Lacerda JF, Barata JT.

Haematologica. 2014 Jun;99(6):1062-8. doi: 10.3324/haematol.2013.096438. Epub 2014 Feb 21.

14.

Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.

Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, Löffler J, Maertens JA, Bell AS, Inforzato A, Barbati E, Almeida B, Santos e Sousa P, Barbui A, Potenza L, Caira M, Rodrigues F, Salvatori G, Pagano L, Luppi M, Mantovani A, Velardi A, Romani L, Carvalho A.

N Engl J Med. 2014 Jan 30;370(5):421-32. doi: 10.1056/NEJMoa1211161.

PMID:
24476432
15.

Chronic myeloproliferative diseases.

de Lacerda JF, Oliveira SN, Ferro JM.

Handb Clin Neurol. 2014;120:1073-81. doi: 10.1016/B978-0-7020-4087-0.00072-3. Review.

PMID:
24365372
16.

Diagnosis and treatment of invasive fungal infections focus on liposomal amphotericin B.

Lacerda JF, Oliveira CM.

Clin Drug Investig. 2013 Feb;33 Suppl 1:S5-14. doi: 10.1007/s40261-012-0023-3. Review.

PMID:
23381977
17.

Invasive fungal disease: challenges in diagnosis and treatment. Foreword.

de Lacerda JF, de Oliveira CM, de Pauw B.

Clin Drug Investig. 2013 Feb;33 Suppl 1:S3. doi: 10.1007/s40261-012-0025-1. No abstract available.

PMID:
23381976
18.

Long-term immune reconstitution of naive and memory t cell pools after haploidentical hematopoietic stem cell transplantation.

Azevedo RI, Soares MV, Albuquerque AS, Tendeiro R, Soares RS, Martins M, Ligeiro D, Victorino RM, Lacerda JF, Sousa AE.

Biol Blood Marrow Transplant. 2013 May;19(5):703-12. doi: 10.1016/j.bbmt.2013.01.017. Epub 2013 Feb 8.

19.

The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma.

Carvalho A, Cunha C, Almeida AJ, Osório NS, Saraiva M, Teixeira-Coelho M, Pedreiro S, Torrado E, Domingues N, Gomes-Alves AG, Marques A, Lacerda JF, da Silva MG, Gomes M, Pinto AC, Torres F, Rendeiro P, Tavares P, Di Ianni M, Medeiros R, Heutink P, Bracci PM, Conde L, Ludovico P, Pedrosa J, Maciel P, Pitzurra L, Aversa F, Marques H, Paiva A, Skibola CF, Romani L, Castro AG, Rodrigues F.

Genes Immun. 2012 Feb;13(2):197-201. doi: 10.1038/gene.2011.59. Epub 2011 Aug 25.

20.

Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.

Gomes AQ, Correia DV, Grosso AR, Lança T, Ferreira C, Lacerda JF, Barata JT, Silva MG, Silva-Santos B.

Haematologica. 2010 Aug;95(8):1397-404. doi: 10.3324/haematol.2009.020602. Epub 2010 Mar 10.

21.

Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival.

Lopes JA, Gonçalves S, Jorge S, Raimundo M, Resende L, Lourenço F, Lacerda JF, Martins C, do Carmo JA, Lacerda JM, Prata MM.

Bone Marrow Transplant. 2008 Nov;42(9):619-26. doi: 10.1038/bmt.2008.207. Epub 2008 Jul 14. Erratum in: Bone Marrow Transplant. 2008 Nov;42(9):635.

PMID:
18622411
22.

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.

Ciceri F, Labopin M, Aversa F, Rowe JM, Bunjes D, Lewalle P, Nagler A, Di Bartolomeo P, Lacerda JF, Lupo Stanghellini MT, Polge E, Frassoni F, Martelli MF, Rocha V; Acute Leukemia Working Party (ALWP) of European Blood and Marrow Transplant (EBMT) Group.

Blood. 2008 Nov 1;112(9):3574-81. doi: 10.1182/blood-2008-02-140095. Epub 2008 Jul 7.

23.

Contemporary analysis of the influence of acute kidney injury (AKI) after myeloablative hematopoietic cell transplantation on long-term patient's survival.

Lopes JA, Jorge S, Gonçalves S, Resina C, Silva S, de Almeida E, Abreu F, Lourenço F, Martins C, Lacerda JF, do Carmo JA, Prata MM.

Bone Marrow Transplant. 2008 Jul;42(2):139-41. doi: 10.1038/bmt.2008.97. Epub 2008 Apr 21. No abstract available. Erratum in: Bone Marrow Transplant. 2008 Nov;42(9):635.

PMID:
18425145
24.

Prognostic utility of the acute kidney injury network (AKIN) criteria for acute kidney injury in myeloablative haematopoietic cell transplantation.

Lopes JA, Jorge S, Silva S, de Almeida E, Abreu F, Martins C, Alves do Carmo J, Lacerda JF, Prata MM.

Bone Marrow Transplant. 2007 Nov;40(10):1005-6. Epub 2007 Sep 17. No abstract available.

PMID:
17873914
25.

Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose thymoglobulin leads to controllable graft-versus-host disease.

Lacerda JF, Martins C, Lourenço F, Carmo JA, Juncal C, Oliveira JJ, Lacerda JM.

Biol Blood Marrow Transplant. 2007 Apr;13(4):494-7. Epub 2007 Feb 22. No abstract available.

26.

Allogeneic stem cell transplantation in patients with myelodysplastic syndrome: outcome analysis according to the International Prognostic Scoring System.

Rubio S, Martins C, Lacerda JF, Carmo JA, Lourenço F, Lacerda JM.

Acta Med Port. 2006 Sep-Oct;19(5):343-7. Epub 2007 Mar 8.

27.

Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation.

Lopes JA, Jorge S, Silva S, de Almeida E, Abreu F, Martins C, do Carmo JA, Lacerda JF, Prata MM.

Bone Marrow Transplant. 2006 Nov;38(10):707. Epub 2006 Oct 2. No abstract available.

PMID:
17013425
28.

An assessment of the RIFLE criteria for acute renal failure following myeloablative autologous and allogeneic haematopoietic cell transplantation.

Lopes JA, Jorge S, Silva S, de Almeida E, Abreu F, Martins C, do Carmo JA, Lacerda JF, Prata MM.

Bone Marrow Transplant. 2006 Sep;38(5):395. No abstract available.

PMID:
16915229
29.

Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.

Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM.

Acta Med Port. 2005 Sep-Oct;18(5):329-37. Epub 2005 Oct 16.

30.

Invasive aspergillosis of the central nervous system after allogeneic stem cell transplantation.

Lacerda JF, Martins C, Carmo JA, Lourenço F, Guedes MM, Sequeira P, Lacerda JM.

J Infect. 2005 Oct;51(3):e191-4.

PMID:
16230206
31.

[Immunologic reconstitution after allogeneic stem cell transplant].

Lacerda JF.

Acta Med Port. 2004 Nov-Dec;17(6):471-80. Epub 2005 Jan 18. Review. Portuguese.

32.

Haploidentical stem cell transplantation with purified CD34+ cells after a chemotherapy-alone conditioning regimen in heavily transfused severe aplastic anemia.

Lacerda JF, Martins C, Carmo JA, Lourenço F, Juncal C, Ismail S, Lacerda JM.

Biol Blood Marrow Transplant. 2005 May;11(5):399-400. No abstract available.

33.

Haploidentical stem cell transplantation with purified CD34 cells after a chemotherapy-alone conditioning regimen.

Lacerda JF, Martins C, Carmo JA, Lourenço F, Juncal C, Rodrigues A, Vilalobos I, Moura MC, Ligeiro D, Martinho A, Lacerda JM.

Biol Blood Marrow Transplant. 2003 Oct;9(10):633-42.

34.

Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.

Lacerda JF, Martins C, Carmo JA, Lourenço MF, Araújo Pereira ME, Rodrigues A, Juncal C, Lacerda JM.

Transplant Proc. 2000 Dec;32(8):2680-1. No abstract available.

PMID:
11134761
35.

[Donor leukocyte infusion after allogeneic stem cell transplantation].

de Lacerda JF.

Acta Med Port. 1999 Jul-Nov;12(7-11):255-64. Review. Portuguese.

37.

Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.

Lacerda JF, Ladanyi M, Louie DC, Fernandez JM, Papadopoulos EB, O'Reilly RJ.

J Exp Med. 1996 Mar 1;183(3):1215-28. Erratum in: J Exp Med 1996 Sep 1;184(3):1199.

39.

Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants.

O'Reilly RJ, Lacerda JF, Lucas KG, Rosenfield NS, Small TN, Papadopoulos EB.

Important Adv Oncol. 1996:149-66. Review. No abstract available.

PMID:
8791134
40.

Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection.

Lacerda JF, Göker E, Kheradpour A, Dennig D, Elisseyeff Y, Jagiello C, O'Reilly RJ, Bertino JR.

Blood. 1995 May 15;85(10):2675-9.

41.

[Treatment of acute promyelocytic leukemia with trans-retinoic acid. Experience of the Santa Maria Hospital, Medical School of Lisbon].

De Lacerda JF, Do Carmo JA, De Moura MC, Guerra ML, Lopes C, Raposo J, Melo A, De Oliveira JJ, De Lacerda JM.

Acta Med Port. 1994 Dec;7(12):717-24. Portuguese.

42.

Leukemia cutis in acute lymphoblastic leukemia.

de Lacerda JF, do Carmo JA, Guerra ML, de Almeida LS, Fernandes A, de Lacerda JM.

J Am Acad Dermatol. 1994 Jun;30(6):1041-3. No abstract available.

PMID:
8188876
43.

Toxicity of tretinoin in acute promyelocytic leukaemia.

de Lacerda JF.

Lancet. 1994 Feb 5;343(8893):360-1. No abstract available.

PMID:
7905173
44.

[Acute promyelocytic leukemia. The therapeutic advances].

de Lacerda JF, do Carmo JA, de Lacerda JM.

Acta Med Port. 1993 Oct;6(10):473-80. Review. Portuguese.

45.

Multiple thrombosis in acute promyelocytic leukaemia after tretinoin.

de Lacerda JF, do Carmo JA, Guerra ML, Geraldes J, de Lacerda JM.

Lancet. 1993 Jul 10;342(8863):114-5. No abstract available.

PMID:
8100880

Supplemental Content

Loading ...
Support Center